R Schleyerbach
- Co-authors
- R. R. BartlettG. H. ThoenesH. U. SchorlemmerClaudius KüchleTieno GermannAlison FinneganKarl LangerM Dimitrijevic
- Topics
- Monoclonal and Polyclonal Antibodies Research (3 papers)Osteoarthritis Treatment and Mechanisms (2 papers)Pharmacological Effects of Natural Compounds (2 papers)
In The Last Decade
R Schleyerbach
14 papers receiving 368 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 142
- Rheumatology 81
- Immunology 68
- Oncology 57
- Surgery 55
Countries citing papers authored by R Schleyerbach
This map shows the geographic impact of R Schleyerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Schleyerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Schleyerbach more than expected).
Fields of papers citing papers by R Schleyerbach
This network shows the impact of papers produced by R Schleyerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Schleyerbach. The network helps show where R Schleyerbach may publish in the future.
Co-authorship network of co-authors of R Schleyerbach
This figure shows the co-authorship network connecting the top 25 collaborators of R Schleyerbach. A scholar is included among the top collaborators of R Schleyerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Schleyerbach. R Schleyerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Leflunomide Inhibits Proliferation of Th 1 Effectors and Biases for Th 2 Cell Differentiation | 1 |
| 2 | 5 | |
| 3 | 28 | |
| 4 | Chondrocytes and antirheumatic drugs. | 6 |
| 5 | 70 | |
| 6 | 155 | |
| 7 | Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. | 37 |
| 8 | Immunosuppressive activity of 15-deoxyspergualin (15-DOS) on various models of rheumatoid arthritis. | 3 |
| 9 | 10 | |
| 10 | 32 | |
| 11 | Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. | 22 |
| 12 | 17 | |
| 13 | Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs. | 1 |
| 14 | 11 |
About R Schleyerbach
R Schleyerbach is a scholar working on Pharmacology, Nephrology and Rheumatology, having authored 14 papers that have together received 398 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Transplantation (28 citations), Rheumatology (81 citations) and Immunology and Allergy (29 citations). R Schleyerbach has collaborated with scholars based in Germany, Canada and Japan. Frequent co-authors include R. R. Bartlett, G. H. Thoenes, H. U. Schorlemmer, Claudius Küchle, Tieno Germann, Alison Finnegan, Karl Langer, M Dimitrijevic, Erwin Rüde and Eric G. Bremer. Their work appears in journals such as Diabetologia, Osteoarthritis and Cartilage and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.